Last reviewed · How we verify

NCT04876144

Kogito: App to Reduce Perinatal Psychosocial Stress

Status unknown NA Last updated 31 August 2021
What this trial tests

NA trial testing Kogito in Psychological Stress in 200 participants. Status unknown.

Timeline
28 July 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorNational Institute of Mental Health, Czech Republic
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment200
Start date28 July 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

National Institute of Mental Health, Czech Republic

Who can join

18 and older, female only, with Psychological Stress or Perinatal Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to test the efectivness of the remote solution for psychosocial stress in pregnant women and postpartum women. Based on the connection of know-how in the field of social sciences and humanities (psychology, volunteer community and peer work with target group) and technological know-how (software design and development), investigators developed an interactive intervention software (Kogito app) to reduce psychosocial stress in the target group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Psychological Stress

Currently open trials in the same condition.

Other National Institute of Mental Health, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04876144.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing